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Abstract: The purpose of this paper is to examine the extent to which trust directly affects public support 
for biotechnology, particularly in applications to food production and genetic modification of crop plants. 
Unlike previous research in which trust is assumed to be exogenous, this paper posits that trust is 
endogenously determined. An econometric model is developed that controls for the endogeneity of trust 
using instrumental variable and selection correction techniques. Using data from the U.S. Biotechnology 
Study, this study finds that the effect of trust on public support is substantially stronger than previous 
estimates.  
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The Effect of Trust on Public Support for Biotechnology: Evidence 
from the U.S. Biotechnology Study, 1997-1998 
 
1. Introduction 
The success of the commercial biotechnology industry depends fundamentally on society's 
acceptance of the genetic modification of crop plants and the use of biotechnology in food production 
(Frewer, Howard, and Aaron, 1998). The reason is straightforward: If the public does not accept or 
support the use of biotechnology in the development and production of food and related agricultural 
products, then consumers will not want to purchase those products. Public trust might be an important 
factor contributing to the commercial success of biotechnology. First, experimental evidence shows that 
trust in the source of information about biotechnology risks and benefits increases an individual's 
intention to purchase products derived from biotechnology (Finlay, Morris, Londerville, and Guelph, 
1999). Second, persistent consumer concerns and low public support for biotechnology are often viewed 
as signs of a lack of public trust (Brom, 2000; Hampel, Pfenning, and Peter, 2001; see also Slovic, 1993; 
Levi, 2000).  
The role of trust in fostering public support is particularly important in the context of risk 
communication (Hunt and Frewer, 2001). This is because consumers perceive that biotechnology 
institutions have a "reporting bias" (i.e., an incentive to overstate benefits and understate risks) and a 
"knowledge bias" (i.e., an inability to fully anticipate all contingencies) when publicly communicating the 
risks and benefits of biotechnology research (see Dholakia and Sternthal, 1997; Eagly, Wood, and 
Chaiken, 1978). As a result, information reported by biotechnology institutions will be discounted by the 
public, especially statements regarding possible risks associated with consumer applications of 
biotechnology research. Because public perceptions of risks and benefits affect the confidence consumers 
place in emerging technologies (Kasperson, Golding, and Tuler, 1992; Peters, Covello, and McCallum, 
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1997), such perceptions also affect the public's willingness to support institutions developing new 
technologies, such as biotechnology industries (Frewer, Howard, and Aaron, 1998).  
Slovic (1993) argues that negative public perceptions can be mitigated by public trust. Hence, 
public trust should improve public support for biotechnology, other things being equal. However, 
empirical evidence linking trust to public support for biotechnology and genetic engineering is mixed. On 
the one hand, Frewer and Shepherd (1994) and Finlay et al (1999) conducted experiments in which 
subjects were exposed to different types of information about biotechnology. They found that trust in 
information sources had no significant effect on support for biotechnology, except, interestingly, in 
increasing purchase intent (Finlay et al). On the other hand, Rosati and Saba (2000) and Siegrist (2000) 
used survey data to find a positive effect of trust. For example, Rosati and Saba used a sample of 434 
Italian respondents to study how public acceptance of biotechnology is affected by trust, perceived risks, 
benefits, uncertainty, and the respondent's moral beliefs about biotechnology. They found that trust had a 
positive and significant effect on acceptance, although trust was the weakest of the five variables tested in 
their model. Siegrist (2000), however, found a more significant, though indirect, effect of trust on public 
support. He hypothesized that trust in institutions using biotechnology affects the perceived benefits and 
risks associated with biotechnology, which in turn affects the public acceptance of biotechnology 
research. He tested his model using information from 1001 randomly sampled Swiss citizens and found 
that the model was consistent with the data. Although the survey data provides positive support for the 
hypothesis that trust affects public support for biotechnology, in reality the evidence is marginal at best – 
Rosati and Saba showed that trust is the weakest of the five variables examined, and Siegrist documented 
only an indirect effect of trust on public support. 
The purpose of this study is to examine the effect of trust on public support for biotechnology. 
The paper begins with the premise that trust is not an "exogenous" variable affecting public support as 
presumed in previous studies, in part because trust involves cognitive processes. According to Hardin 
(2001), although some trust might be noncognitive in that people just have a disposition to trust or not 
trust, "one is most likely to have first made a cognitive selection of whom to trust" (p. 6; emphasis in 
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original). Thus, understanding why people trust and what factors affect that trust is an important part of 
the problem of assessing the impact of trust on public support for biotechnology institutions. In effect, 
this requires that trust be treated as an endogenous rather than exogenous factor in models of public 
support for biotechnology. If the endogeneity of trust is not controlled for, then empirical estimates of the 
effect of trust on biotechnology support will be biased. In fact, a failure to control for the endogeneity of 
trust might explain the mixed evidence found in previous studies (cited above) linking trust to public 
support. In this paper, data from the United States Biotechnology Study is used to examine the impact of 
trust on public support for biotechnology while controlling for the endogeneity of trust. This analysis 
finds that, after controlling for the endogeneity of trust, the impact of trust is more than four times 
stronger than uncorrected estimates. Moreover, trust is shown to have a stronger impact than perceived 
risks from biotechnology research, expected benefits, and all other variables examined. This suggests that 
trust might be a more important factor affecting society's acceptance of biotechnology research than 
previously recognized.  
 
2. Trust and the Estimation of the Trust Effect 
Trust can be viewed as an expectation that one would not be exploited by another (James, 2002a). 
Thus, "uncertainty and vulnerability are the core elements of trust relations" (Heimer, 2001, p. 43). To say 
that trust affects the public support of biotechnology means that individuals who trust biotechnology 
institutions in the development of agricultural products or applications will not expect to be exploited in 
the sense that such products or applications are ultimately determined to be unsafe or ineffective. This 
expectation is based on the perceived trustworthiness (i.e., the "reporting bias") and competence (i.e., the 
"knowledge bias") of the biotechnology institutions (see James, 2002a; Levi, 2000). That is, if the public 
is confident that it would not be exploited (e.g., the public perceives biotechnology institutions to be 
trustworthy and competent), then the public would be more likely to trust and, in turn, support 
biotechnology institutions. However, if the public expects to be exploited (e.g., public perceptions are that 
biotechnology institutions have a vested interest to misrepresent the safety and efficacy of biotechnology 
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or have insufficient knowledge to conduct biotechnology-based research and development), then the 
public would be less willing to trust and hence support biotechnology institutions (see Hunt and Frewer, 
2001).  
The equation that models the direct effect of trust on the public support of biotechnology 
institutions is  
(1) iiii uTXS ++′= δβ , 
where Si is the measure of public support, β is a vector of parameters, Xi is a vector of other explanatory 
variables, Ti is a dummy variable equal to one if the individual trusts biotechnology institutions and zero 
otherwise, δ is a coefficient measuring the effect of trust on public support, ui is an error term, and i is an 
index for individuals i . Does the parameter δ accurately measure the effect of trust on public 
support? Earlier empirical studies answer this question by estimating the size and significance of δ in 
models structurally similar to equation (1). These estimates of δ, however, will not accurately measure the 
effect of trust on public support for biotechnology if trust is a decision variable reflecting, for instance, 
the public's expectations of the trustworthiness and competence of biotechnology institutions. The reason 
is that if trust (T
NK1=
i) and public support (Si) are dependent variables, then the variable Ti in equation (1) will 
be correlated with the error term ui. The implication is that regression estimates of δ will not correctly 
describe the effect of trust on public support for biotechnology research.  
In order to model correctly the relationship between trust and public support of biotechnology, a 
separate equation is required in which trust is the dependent variable. Coleman (1990) and James (2002b) 
develop models of trust in which the decision to trust is based on an examination of the expected gains 
from correctly trusting relative to the expected losses from mistrusting (i.e., when trust is exploited). If 
 is the expected benefit when individual i trusts biotechnology institutions, and is the expected loss 
from mistrusting (e.g., when biotechnology products or applications are determined to be unsafe or 
ineffective), then a person would trust if T . That is, we observe 
B
iT
L
iT
L
i
B
i T> 1=iT  if T ; conversely, 
 if T . The decision to trust can therefore be modeled by the equation 
L
ii T
B >
0=iT LiBi T≤
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(2) iii ZT εγ +′= , 
where γ is a vector of parameters, Zi is a set of explanatory variables, and εi is the error term, such that 
 1=iT  iff ii Zγε ′−>  
 0=iT  otherwise. 
According to Coleman (1990) and James (2002b), the set of explanatory variables, Zi, would include 
elements representing an individual's assessments of the potential losses from being exploited, the 
potential gains from correctly trusting, and the probability of not being exploited because of 
untrustworthiness or incompetence. Specifically, the probability that a person would trust (i.e., 
)( ii Zprob γε ′−> ) increases when the losses from misplaced trust decrease, the gains from correctly 
trusting increase, and the probability that trust will not be exploited increases, other things being equal.  
If equation (1) is estimated without correcting for the endogeneity of trust modeled by equation 
(2), then the error terms ui and εi will be correlated resulting in the biased estimation of δ in equation (1). 
Vella and Verbeek (1999) explain that there are two approaches to estimating correctly models such as 
equation (1), in which an explanatory variable is also a dependent variable modeled by equation (2). One 
approach is to replace Ti in equation (1) with an instrumental variable expected to be correlated with Si 
but not correlated with the error term ui. The other approach is to correct for the endogeneity of Ti by 
including a selection-correcting factor, λi, in equation (1), consistent with the work of Heckman (1979).  
According to the instrumental variable approach, two steps are followed. First, equation (2) is 
estimated with a Probit analysis, and then the predicted probabilities of Ti, denoted as T , are inserted in 
equation (1) in place of T
iˆ
i. These fitted values for Ti will be correlated with Si but not with ui (see Greene, 
2000, ch. 9). Second, the effect of trust on public support, δ, is determined by estimating the following 
corrected version of equation (1): 
(3) . iiii TXS µδβ ++′= ˆ
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According to the selection correction approach, the correction factor necessary to resolve the 
endogeneity of Ti is identified by recognizing that the conditional expectation of Si when T  (that is, 
when 
1=i
ii Zγε ′−> ) is  
(4a) )|( iii ZSE γε ′−>  )|( iiii ZuEX γεδβ ′−>++′=  
  =
)(1
)(
i
i
u Z
Z
X γi
γφρσ ′−Φ−
′−δβ ++′ , 
and the conditional expectation of Si when 0=iT  is 
(4b) )|( iii ZSE γε ′−≤  )|( iiii ZuEX γεβ ′−≤+′=  
  =
)(
)(
i
i
Z
Z
X γui
γφρσβ ′−Φ
′−−+′ , 
where )(⋅φ  is the density function and )(⋅Φ  is the cumulative density function of the standard normal 
distribution, ρ is the correlation of the error terms ui and εi, and σu is the standard deviation of ui. The 
terms 
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−−
 in equations (4a) and (4b) respectively are "inverse Mill's ratios," 
and they are required to correct for the selection bias of equation (1) (see Greene, 2000, ch. 20; Vella and 
Verbeek, 1999; Maddala, 1983). In order to make the selection bias correction, two steps are followed. 
First, equation (2) is estimated using Probit analysis and an estimate of  is obtained, where )'ˆ(ˆ ii Zγλ iZ'γˆ  
is the predicted value from equation (2), and  
(5) 
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Second the effect of trust on public support, δ, is determined by estimating the following corrected 
version of equation (1): 
(6) , iiiii TXS ηλθδβ +⋅++′= )(ˆ
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in which  is added as a regressor. In this model, the coefficient θ has an important economic 
interpretation. If 
)(ˆ ⋅iλ
0>θ , then individuals who are willing to support biotechnology research will do so 
whether or not they trust, or even in the absence of trust (characterizing a hierarchal structure to the 
relationship between trust and support). However, if 0<θ , then public support is higher because 
individuals trust biotechnology institutions (characterizing a comparative advantage structure to the trust-
support relationship) and thus, without trust, public support will be lower. In other words, 0>θ  indicates 
that the effect of trust is overestimated in models such as equation (1) that do not include a correction 
factor, while 0<θ  indicates that the effect of trust is underestimated without the correction. Note that 
from a theoretical perspective, the expected sign of θ is ambiguous. However, because it is hypothesized 
that trust is an important factor affecting the public acceptance of biotechnology research, the sign of θ is 
expected to be negative and significant, indicating that uncorrected models underestimate the impact of 
trust on public support for biotechnology. 
 
3. Data 
The effect of trust on public support for biotechnology research, particularly in applications to 
food and agricultural production, was examined using data from the United States Biotechnology Study, 
1997-1998 (see Miller, 2000), created from telephone interviews of 1,067 randomly sampled U.S. 
citizens, 18 years of age and older, between November 1997 and February 1998. In this sample, 49.8 
percent of respondents were male, 58.7 percent of respondents had at least some post high school 
education, and the average respondent was 45 years old. Respondents were asked a variety of questions, 
including questions regarding their knowledge of and attitudes towards biotechnology, their 
understanding of biotechnology science, their interest in biotechnology news, and their confidence in 
scientists and institutions engaged in biotechnology research.  
In order to examine the effect of trust on public support for biotechnology, measures of public 
support and public trust were created, in addition to a set of control variables. The measures of public 
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support for the use of biotechnology in the production of food and drinks (SBIOFOOD) and the use of 
genetic modification of crop plants (SBIOPLANTS) were based on Gaskell's (2000) definition of support. 
According to this definition, individuals support biotechnology if they believe that it is (a) useful, (b) 
morally acceptable, and (c) should be encouraged. Therefore, respondents were coded as supporting the 
use of biotechnology in the production of food and drinks (SBIOFOOD=1) if they reported that they 
definitely agree or tend to agree that the "use of modern biotechnology in the production of food and 
drinks" (a) "is useful," (b) "is morally acceptable," and (c) "should be encouraged" (SBIOFOOD=0 
otherwise). Similarly, respondents were coded as supporting genetic modification of crop plants 
(SBIOPLANTS=1) if they reported that they definitely agree or tend to agree that "using biotechnology to 
insert genes from one plant into a crop plant" (a) "is useful," (b) "is morally acceptable," and (c) "should 
be encouraged" (SBIOPLANTS=0 otherwise). Respondents were coded as trusting biotechnology 
institutions (TRUST=1) if they placed a lot or some confidence in university scientists and food 
manufacturers (TRUST=0 otherwise). As shown in Table 1, which presents the sample means and 
standard deviations for all variables used in this study, 51.2 percent of respondents sampled support 
biotechnology applications in food and drink production, and 60.4 percent support the genetic 
modification of crop plants. That respondents are relatively more supportive of genetic modifications to 
crop plants than biotechnology applications in food production is consistent with the findings of Hoban 
(1998), Gaskell (2000), and Hampel et al (2000). Moreover, nearly 53 percent of respondents place at 
least some trust in biotechnology institutions.  
In addition to TRUST as an explanatory variable, the other variables expected to affect public 
support for the use of biotechnology in food production (SBIOFOOD) and the genetic modification of 
crop plants (SBIOPLANTS), were identified based on the earlier studies linking trust to support (cited 
above). These variables are the following (sample means and standard deviations in Table 1): 
• RISKYBFOOD: A dummy equal to one if the respondent definitely agreed or tended to agree 
that the use of biotechnology in the production of food and drinks is risky to society; zero 
otherwise. 
• HEARDBFOOD: A dummy equal to one if the respondent had heard of the use of 
biotechnology in the production of food and drinks; zero otherwise. 
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• RISKYBPLANTS: A dummy equal to one if the respondent definitely agreed or tended to 
agree that using biotechnology to insert genes from one plant into a crop plant is risky to 
society; zero otherwise. 
• HEARDBPLANTS: A dummy equal to one if the respondent had heard of using 
biotechnology to insert genes from one plant into a crop plant; zero otherwise. 
• IMPROVELIFE: A dummy equal to one if the respondent believed that biotechnology or 
genetic engineering will improve our way of life in the next 20 years; zero otherwise. 
• NEGFEEL: A dummy equal to one if the respondent has strongly negative or negative 
feelings about modern biotechnology; zero otherwise. 
• UNDERSTAND: A dummy equal to one if the respondent correctly answered each of the 
following three True/False biotechnology-related questions: (1) DNA regulates inherited 
characteristics in all plants, animals, and humans (correct answer True); (2) Ordinary 
tomatoes do not contain genes while genetically modified tomatoes do (correct answer False); 
and (3) By eating a genetically modified fruit, a person's genes could also become modified 
(correct answer False); zero otherwise. 
• COLLEGE: A dummy equal to one if the respondent had completed some college degree; 
zero otherwise. 
• MALE: A dummy equal to one if the respondent is male; zero otherwise. 
• TRUST_HAT: The predicted probability for Ti, denoted as , from the estimation of 
equation (2). 
iTˆ
• LAMBDA: The selection correction factor, obtained by calculating the inverse Mill's ratios 
using the fitted values of iZ'γˆ  from the estimation of equation (2). 
In order to make predictions on the expected signs of the effect of the independent variables on 
public support, note that Siegrist (2000) and Rosati and Saba (2000) reported that increases in perceived 
risks tend to reduce public acceptance, while increases in the expected benefits of biotechnology research 
improve public acceptance (see also Wolt and Peterson, 2000; Gaskell, 2000; Hampel, Pfenning, and 
Peters, 2000). Therefore, the coefficients on the risk variables RISKYBFOOD and RISKYBPLANTS are 
expected to be negative, while the coefficient on IMPROVELIFE, which measures the perception that 
biotechnology will result in social benefits, is expected to be positive. Additionally, Rosati and Saba 
(2000) found that an increased sense of uncertainty regarding biotechnology reduced public acceptance. 
In this study, uncertainty is proxied by the variable NEGFEEL – a greater sense of uncertainty felt by a 
respondent would likely translate into stronger negative feelings about biotechnology, thus reducing the 
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degree to which biotechnology is supported; therefore, the coefficient for NEGFEEL is predicted to be 
negative. The expected signs of the variables HEARDBFOOD, HEARDBPLANTS, UNDERSTAND, 
and COLLEGE are not readily predictable, since the fact that respondents had heard of biotechnology or 
have an understanding of the science involved could indicate an interest in the issues, but not necessarily 
result in either support or lack of support for biotechnology research. The coefficient on MALE is 
expected to be positive because other researchers (Hampel et al, 2000; Siegrist, 2000) have found that 
men are generally more accepting of biotechnology research than women. 
In order to estimate equation (2), proxies for the potential losses and gains from placing trust in 
biotechnology, as well as the expected probability that such trust would be exploited, are required (see 
Coleman, 1990; James, 2002b). The potential loss resulting from misplaced trust in biotechnology 
institutions is proxied by the dummy variable RISKY, which takes the value of one if RISKYBF=1 and 
RISKYBP=1; zero otherwise. Increases in perceived risks (or losses) from biotechnology are expected to 
reduce trust (see Hunt and Frewer, 2001); therefore, the coefficient for RISKY is expected to be negative. 
The potential for gains is operationalized by the dummy variable PERSBNFT, which equals one if the 
respondent strongly agrees or agrees that biotechnology will personally benefit in the next 5 years, or has 
already personally benefited, himself or his family; zero otherwise. Individuals tend to trust when they 
have an interest in trusting (James, 2002b), perhaps because they expect to benefit personally from the 
biotechnology research (see Hunt and Frewer, 2001); therefore, the coefficient of PERSBNFT is expected 
to be positive. The respondent's assessment of the likelihood that trusting would be exploited is measured 
by the dummy variable GOVREGOK, which equals one if the respondent strongly agrees or agrees that 
"current regulations are sufficient to protect people from any risks linked to modern biotechnology;" zero 
otherwise. Individuals tend to trust if they believe the agent in whom they place trust has an incentive to 
be trustworthy (see James, 2002a, 2002b) and is competent (see Levi, 2000). In the case of biotechnology, 
respondents may be willing to trust if they perceive that biotechnology scientists and institutions are not 
motivated wholly by greed over the public interest and that they have the necessary knowledge to conduct 
biotechnology activities (see Hampel at al, 2000). This expectation could be created by the perception that 
 10
behavior is sufficiently regulated; therefore, the coefficient on GOVREGOK is expected to be positive. In 
addition, COLLEGE and MALE were included in the trust equation to control for individual respondent 
characteristics. 
 
4. Results 
Table 2 presents the results of the Probit analysis of equation (2), in which TRUST is the 
dependent variable. The results indicate that the perception of risk reduces trust in biotechnology 
institutions, while the expectation of personal benefits and the belief that biotechnology institutions are 
sufficiently regulated support trust. Although the coefficient in a Probit model is not directly interpretable 
in terms of the magnitude of the effect on the probability of trust, it is possible to calculate the change in 
probability resulting from a change in the independent variable by multiplying the coefficient by the 
average density function of the standard normal distribution evaluated for each observation (Greene, 
2000, ch. 19). This calculation creates the estimated slope parameters reported in column 3 of Table 2. 
Observe that the perception of risk reduces the probability of trust by 11.4 percent. Conversely, the 
expectation that biotechnology research will produce personal benefits increases the likelihood of trust by 
22.1 percent. Similarly, the belief the biotechnology institutions are adequately regulated increases the 
probability of trust by 12.1 percent. Thus, it appears that trust in biotechnology would be improved by all 
three factors hypothesized to affect trust generally – reducing perceived risks, increasing perceived 
benefits, and ensuring that biotechnology institutions appropriate incentives for trustworthiness and 
competence.  
Tables 3 and 4 present the results of the analysis of public support for biotechnology in the 
production of food and drink (SBIOFOOD), and public support for the genetic modification of crop 
plants (SBIOPLANTS), respectively, as functions of trust and other factors. Column 2 of Table 3 presents 
an estimation of equation (1) using ordinary least squares (OLS) regression analysis, in which 
SBIOFOOD (support for biotechnology in food production) is the dependent variable. In this linear 
probability formulation of the model, trust improves the likelihood of public support by nearly 16 percent. 
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However, because SBIOFOOD is a dichotomous variable, the linear probability (OLS) model produces 
biased estimates that are resolved through the use of a Probit analysis. In column 3 of Table 3, a Probit 
formulation of equation (1) is estimated, showing that trust increases the probability of public support by 
15.4 percent. In addition, all other variables are significant, and for variables in which predictions are 
made, the signs are as expected. For example, if respondents believe that the use of biotechnology in food 
production is risky (RISKYBFOOD), then the probability of public support is reduced by more than 17 
percent. Moreover, respondents who had heard of biotechnology applications in food production 
(HEARDBFOOD) show an increased probability of support of nearly 19 percent, and respondents who 
have an expectation that biotechnology will produce future benefits (IMPROVELIFE) increase public 
support by almost 13 percent. 
Because trust is a dependent variable modeled by equation (2), the uncorrected Probit estimation 
of equation (1) presented in column 3 produces biased estimates of the effect of trust on public support for 
biotechnology in the production of food. Accordingly, corrections are required. In column 4 of Table 3, 
equation (3) is estimated in which the instrumental variable (IV), TRUST_HAT, is used in place of 
TRUST. In column 5, equation (6) is estimated, in which the selection correction factor, LAMBDA, is 
included as a regressor to control for the endogeneity of the trust variable. In both models, the effect of 
trust is to increase the probability of public support for biotechnology in food production by 66 percent, a 
more than fourfold increase compared to the uncorrected estimate of the trust coefficient obtained by the 
standard Probit analysis. Thus, corrected estimations of equation (1) show a significant improvement in 
the effect of trust on public support. Additionally, the coefficient on LAMBDA is significant and 
negative, suggesting the decision to trust is important and that uncorrected models underestimate the 
effect of trust on public support of biotechnology research. Because the coefficient on LAMBDA is 
negative and because the magnitude of the trust coefficient in the corrected estimates of equation (1) are 
substantially larger than the other coefficients, one cannot reject the hypothesis that individuals support 
biotechnology institutions in part because they trust the scientists and institutions engaged in 
biotechnology research.  
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An examination of the effect of trust and other factors on SBIOPLANTS (support for 
biotechnology research involving the genetic modification of plants), reported in Table 4, reveals similar 
findings. In the linear probability model estimated using OLS regression (column 2 of Table 4) and the 
Probit model (column 3), trust increases the probability of support by 10 percent. In comparison, when 
the endogeneity of trust is corrected, as in the IV (column 4) and selection factor (column 5) models, trust 
increases the probability of public support by 45 to 51 percent. Interestingly, risk becomes relatively more 
important, and the effect of trust less so, when biotechnology is applied to genetically modifying crop 
plants than producing food and drink products.  
 
5. Conclusions 
This study has examined the relationship between trust and public support of biotechnology 
institutions, particularly when biotechnology is applied to food production and when crop plants are 
genetically modified. In this study, trust is modeled as an endogenous rather than exogenous factor 
affecting public trust, in part because there is a cognitive aspect to the question of whether or not people 
trust biotechnology institutions. When the relationship between trust and public support for biotechnology 
is correctly modeled, using instrumental variables or selection-correction techniques to control for the 
endogeneity of trust, trust is found to be a more important determinant of public support than earlier 
studies indicate. Indeed, the estimated impact of trust increases at least fourfold when the endogenously 
corrected models of public support are compared to the uncorrected ones. To be precise, according to the 
data examined in this study from the U.S. Biotechnology Study, trust increases public support for 
biotechnology applications in food and drink production by 66 percent in models that control for the 
endogeneity of trust, while uncorrected models show the effect of trust to be roughly 15 percent. 
Similarly, corrected models linking trust to public support for the genetic modification of crop plants 
show that trust increases public support by between 45 and 50 percent, compared to the 10 percent effect 
estimated from the uncorrected models.  
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Additionally, the estimation of corrected models shows that trust is the most important factor 
affecting public support for biotechnology among the variables examined in this study, far exceeding the 
impact of perceived risks and benefits, for instance. This suggests that risk communication efforts to 
improve the public's perceptions of risks and benefits alone may not be fully effective in improving 
public support for biotechnology. Rather, efforts to increase public trust – or to be more precise, efforts to 
improve the perceived trustworthiness and competence of biotechnology institutions – might also be 
necessary in improving the public support for and acceptance of biotechnology research and applications 
in agribusiness activities. Clearly, more research is required in determining more precisely how trust and 
other factors affect public support and acceptance of biotechnology. For example, if the effect of trust on 
public support is endogenously determined, are there other factors affecting public support, such as 
perceived risks and benefits, that are also endogenous? In terms of public policy, which is more important 
– risk communication strategies to educate the public regarding the risks and benefits of biotechnology or 
efforts to improve public trust through institutional changes that improve the trustworthiness and 
competence of individuals working in biotechnology industries?  
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 Tables 
Table 1. Sample Means and Standard Deviations for Variables 
 
Variable 
 
Mean 
Standard 
Deviation 
SBIOFOOD .512 .500 
RISKYBFOOD .500 .500 
HEARDBFOOD .713 .452 
SBIOPLANTS .604 .489 
RISKYBPLANTS .387 .487 
HEARDBPLANTS .694 .461 
IMPROVELIFE .599 .490 
NEGFEEL .142 .350 
UNDERSTAND .379 .485 
COLLEGE .475 .500 
MALE .498 .500 
TRUST .529 .499 
TRUST_HAT (T ) iˆ .529 .145 
LAMBDA ( ) iλˆ 0.000 .777 
RISKY .282 .450 
PERSBNFT .754 .431 
GOVREGOK .370 .483 
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 Table 2. Probit Regression of Trust Model  
   
Variable Coefficient Est. Slope 
INTERCEPT -0.363 a 
(0.100) 
 
-0.135 
RISKY -0.308 a 
(0.088) 
 
-0.114 
PERSBNFT 0.597 a 
(0.094) 
 
0.221 
GOVREGOK 0.327 a 
(0.085) 
 
0.121 
COLLEGE -0.192 a 
(0.080) 
 
-0.071 
MALE 0.086 
(0.080) 
 
0.032 
Chi-Square (DF) 
Ave Density 
92.965a (5) 
.371 
 
Standard errors in parentheses. 
Estimated Slope calculated by multiplying Coefficient with Density. 
a significant at 1%; b significant at 5%; c significant at 10% 
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Table 3. Estimation of Models of Support of Biotechnology in Food and Drink Production 
 OLS Probit Probit with IV Probit with λ 
Variable Coefficient Coefficient Coefficient Coefficient 
INTERCEPT 0.163 a 
(0.040) 
[0.163] 
-1.001 a 
(0.125) 
[-0.322] 
 
-1.929 a 
(0.225) 
[-0.617] 
 
-2.017 a 
(0.225) 
[-0.635] 
 
RISKYBFOOD -0.180 a 
(0.028) 
[-0.180] 
-0.534 a 
(0.084) 
[-0.172] 
 
-0.427 a 
(0.087) 
[-0.137] 
 
-0.337 a 
(0.087) 
[-0.106] 
 
HEARDBFOOD 0.194 a 
(0.031) 
[0.194] 
0.579 a 
(0.094) 
[0.186] 
 
0.582 a 
(0.094) 
[0.186] 
 
0.609 a 
(0.092) 
[0.192] 
 
IMPROVELIFE 0.137 a 
(0.029) 
[0.137] 
0.399 a 
(0.088) 
[0.128] 
 
0.367 a 
(0.089) 
[0.117] 
 
0.317 a 
(0.088) 
[0.100] 
 
NEGFEEL -0.107 a 
(0.040) 
[-0.107] 
-0.322 a 
(0.125) 
[-0.104] 
 
-0.247 b 
(0.126) 
[-0.079] 
 
-0.228 b 
(0.120) 
[-0.072] 
 
UNDERSTAND 0.117 a 
(0.029) 
[0.117] 
0.350 a 
(0.090) 
[0.113] 
 
0.335 a 
(0.090) 
[0.107] 
 
0.320 a 
(0.093) 
[0.101] 
 
COLLEGE 0.114 a 
(0.029) 
[0.114] 
0.340 a 
(0.088) 
[0.109] 
 
0.476 a 
(0.093) 
[0.152] 
 
0.551 a 
(0.098) 
[0.174] 
 
MALE 0.104 a 
(0.027) 
[0.104] 
0.314 a 
(0.084) 
[0.101] 
 
0.258 a 
(0.085) 
[0.083] 
 
0.297 a 
(0.085) 
[0.094] 
 
TRUST 0.157 a 
(0.028) 
[0.157] 
0.478 a 
(0.085) 
[0.154] 
 
--- 2.101 a 
(0.324) 
[0.662] 
 
TRUST_HAT (T ) iˆ ---  
 
--- 2.076 a 
(0.328) 
[0.664] 
 
--- 
LAMBDA ( ) iλˆ ---  
 
--- --- -1.023 a 
(0.203) 
[-0.322] 
 
Adjusted R2 
Chi-square (DF) 
Ave Density 
0.219 
--- 
1.000 
--- 
266.325a (8) 
0.322 
--- 
275.715a (8) 
0.320 
--- 
268.809a (8) 
0.315 
Standard errors in parentheses. Estimated slope calculated by multiplying coefficient with average density in 
brackets. 
a significant at 1%; b significant at 5%; c significant at 10% 
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Table 4. Estimation of Models of Support for Genetic Modification of Crop Plants  
 OLS Probit Probit with IV Probit with λ 
Variable Coefficient Coefficient Coefficient Coefficient 
INTERCEPT 0.309 a 
(0.038) 
[0.309] 
 
-0.566 a 
(0.115) 
[-0.182] 
 
-1.280 a 
(0.218) 
[-0.410] 
 
-1.264 a 
(0.220) 
[-0.398] 
 
RISKYBPLANTS -0.238 a 
(0.028) 
[-0.238] 
 
-0.703 a 
(0.087) 
[-0.226] 
 
-0.554 a 
(0.093) 
[-0.177] 
 
-0.653 a 
(0.093) 
[-0.206] 
 
HEARDBPLANTS 0.258 a 
(0.031) 
[0.258] 
 
0.734 a 
(0.093) 
[0.236] 
 
0.692 a 
(0.093) 
[0.221] 
 
0.801 a 
(0.091) 
[0.252] 
 
IMPROVELIFE 0.083 a 
(0.029) 
[0.083] 
 
0.247 a 
(0.089) 
[0.080] 
 
0.218 b 
(0.090) 
[0.070] 
 
0.198 b 
(0.090) 
[0.062] 
 
NEGFEEL -0.019 
(0.040) 
[-0.019] 
 
-0.050 
(0.122) 
[-0.016] 
 
-0.002 
(0.123) 
[-0.001] 
 
-0.042 
(0.117) 
[-0.013] 
 
UNDERSTAND 0.117 a 
(0.030) 
[0.117] 
 
0.370 a 
(0.093) 
[0.119] 
 
0.372 a 
(0.094) 
[0.119] 
 
0.425 a 
(0.097) 
[0.134] 
 
COLLEGE 0.074 a 
(0.028) 
[0.074] 
 
0.231 a 
(0.088) 
[0.074] 
 
0.337 a 
(0.092) 
[0.108] 
 
0.398 a 
(0.099) 
[0.125] 
 
MALE 0.060 b 
(0.027) 
[0.060] 
 
0.176 b 
(0.085) 
[0.057] 
 
0.121 
(0.087) 
[0.039] 
 
0.159 c 
(0.087) 
[0.050] 
 
TRUST 0.100 a 
(0.028) 
[0.100] 
 
0.318 a 
(0.086) 
[0.102] 
 
--- 1.433 a 
(0.335) 
[0.451] 
 
TRUST_HAT (T ) iˆ ---  
 
--- 1.589 a 
(0.336) 
[0.508] 
 
--- 
LAMBDA ( ) iλˆ ---  
 
--- --- -0.676 a 
(0.211) 
[-0.213] 
 
Adjusted R2 
Chi-square (DF) 
Ave Density 
0.195 
--- 
1.000 
--- 
231.427a (8) 
0.319 
--- 
240.225a (8) 
0.317 
--- 
284.337a (8) 
0.303 
Standard errors in parentheses. Estimated slope calculated by multiplying coefficient with average density in 
brackets. 
a significant at 1%; b significant at 5%; c significant at 10% 
 21
